Edition:
United Kingdom

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.53USD
12 Dec 2018
Change (% chg)

$0.01 (+0.66%)
Prev Close
$1.52
Open
$1.56
Day's High
$1.56
Day's Low
$1.51
Volume
4,848
Avg. Vol
68,236
52-wk High
$17.22
52-wk Low
$1.12

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -1.08 December 13 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 4 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 4 3.50 7.02 0.00 8.10
Quarter Ending Mar-19 3 0.00 0.00 0.00 --
Year Ending Dec-18 4 3.54 7.10 0.00 12.40
Year Ending Dec-19 4 2.54 10.10 0.00 2.28
Earnings (per share)
Quarter Ending Dec-18 4 -1.08 -0.37 -2.04 -1.44
Quarter Ending Mar-19 2 -1.61 -1.18 -2.04 --
Year Ending Dec-18 4 -4.70 -0.86 -7.56 -5.52
Year Ending Dec-19 4 -4.69 -2.40 -7.92 -5.08

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.00 0.02 0.01 300.00
Quarter Ending Jun-18 0.00 0.02 0.01 300.00
Quarter Ending Mar-18 0.00 0.02 0.01 400.00
Quarter Ending Dec-17 0.74 0.02 0.72 97.56
Quarter Ending Sep-17 0.86 0.02 0.85 97.92

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3.50 3.50 1.75 0.00 8.10
Quarter Ending Mar-19 0.00 0.00 0.00 0.00 --
Year Ending Dec-18 3.54 3.54 1.43 0.03 12.40
Year Ending Dec-19 2.54 2.54 2.03 0.03 2.28

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 1 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 0 0
Earnings